Display options
Share it on

Exp Ther Med. 2014 May;7(5):1359-1363. doi: 10.3892/etm.2014.1594. Epub 2014 Feb 28.

Contrast-enhanced ultrasound analysis of tissue perfusion in tumor-bearing mice following treatment with endostatin combined with radiotherapy.

Experimental and therapeutic medicine

Wei Ge, Yongfa Zheng, Zezhang Tao

Affiliations

  1. Department of Oncology, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, P.R. China.
  2. Department of Otolaryngology, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, P.R. China.

PMID: 24940439 PMCID: PMC3991532 DOI: 10.3892/etm.2014.1594

Abstract

The aim of this study was to observe the effects of Endostar (recombinant human endostatin) and radiotherapy, singly or in combination, on blood flow in mouse tumour tissue using ultrasound imaging. The ultrasound contrast agent, SonoVue, was used for the contrast-enhanced ultrasound examinations. SonoLiver software was used to analyse dynamic vascular patterns (DVPs) in the contrast process. Blood perfusion data were collected and statistical analysis was performed for data processing. Results were presented as DVP curves and quantitative parameters. Quantitative parameters showed statistically significant (P<0.05) differences in peak strength, rise time, time to peak and mean transit time among the various treatment groups. Changes in tumour blood perfusion were quantified by the assessment of contrast-enhanced ultrasound parameters. The results indirectly reflected the degree of change in angiogenesis in the tumour following experimental intervention. Ultrasound contrast imaging effectively showed the extent of the changes in vascularity and flow state. Therefore, contrast-enhanced ultrasound is suitable for use as an indicator of blood flow changes in an experimental model.

Keywords: dynamic vascular model reconstruction; endostatin; radiotherapy; ultrasonography

References

  1. Ultrasound Med Biol. 2012 Jun;38(6):1019-29 - PubMed
  2. J Breast Cancer. 2013 Jun;16(2):208-13 - PubMed
  3. Exp Ther Med. 2012 Jun;3(6):1018-1022 - PubMed
  4. Clin Exp Med. 2012 Jun;12(2):89-95 - PubMed
  5. Invest Radiol. 2010 Oct;45(10):669-74 - PubMed
  6. J Urol. 2011 Jun;185(6):2359-65 - PubMed
  7. Phys Med Biol. 2009 Mar 21;54(6):R27-57 - PubMed
  8. Cancer Sci. 2009 Aug;100(8):1510-9 - PubMed
  9. Ultrasonics. 2011 Jan;51(1):102-6 - PubMed
  10. J Cancer Res Clin Oncol. 2010 Aug;136(8):1201-11 - PubMed
  11. J Huazhong Univ Sci Technolog Med Sci. 2011 Feb;31(1):62-66 - PubMed
  12. PLoS One. 2012;7(4):e34646 - PubMed
  13. Eur J Nucl Med Mol Imaging. 2010 Aug;37 Suppl 1:S65-85 - PubMed
  14. Asian Pac J Cancer Prev. 2012;13(3):923-6 - PubMed
  15. Liver Int. 2005 Oct;25(5):954-61 - PubMed
  16. Zhongguo Fei Ai Za Zhi. 2010 Apr;13(4):386-90 - PubMed
  17. Invest Radiol. 2012 Jan;47(1):18-24 - PubMed
  18. Eur Radiol. 2011 Mar;21(3):604-15 - PubMed
  19. Mol Biol Rep. 2012 Jan;39(1):89-95 - PubMed

Publication Types